|Articles|September 2, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-09-02-2018
  • Volume 42
  • Issue 9

Isolator and Filling Machine for Vials

groninger and SKAN have collaborated to develop Integra, a production line concept that integrates both an isolator and filling machine for vials with a large capacity range.

groninger and SKAN have collaborated to develop Integra, a production line concept that integrates both an isolator and filling machine for vials with a large capacity range.

The product was developed with a focus on processing toxic products. Features include shorter decontamination cycles and simplified cleaning. The integration of the filling machine into the isolator and the integration of the SKANFOG decontamination system allows the line to be cleaned and decontaminated in approximately 30 minutes with accessibility for operating personnel, according to groninger. Increased security and support for format changes enabled by the use of quick response codes gives operators a better overview of position, installation order, and recipe selection.

Different line configurations are available with either standardized open restricted access barrier systems or isolator modules and are capable of a maximum production output of 400 vials per minute, groninger reports.

groninger


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.